In more recent decades, HPV has been shown as a risk factor for developing head and neck cancer. Head and neck cancer covers everything from throat, tongue, and tonsil cancer to laryngeal, mouth, and ...

A lump in your throat, along with ear pain or a change in voice, could mean the unthinkable: cancer. Dr. Seerat Poonia, a head and neck surgeon at Swedish, is learning that throat cancers linked to ...

Head and neck cancers affect the tissues of the mouth, throat, sinuses, and surrounding areas. They can impact crucial functions like breathing, swallowing, and talking. There are several types of ...

Please provide your email address to receive an email when new articles are posted on . Patients with head and neck cancer have a higher risk for depression than those with other cancers. Rates of ...

The HPV vaccine is linked to a drastic reduction in head and neck cancers in adolescent boys and men, new research finds. HPV, or human papillomavirus, is a sexually transmitted infection responsible ...

This guide for newly diagnosed patients provides key information to help you understand your options and have informed conversations with your oncologist. A diagnosis of head and neck cancer can bring ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

A new study suggests that cannabis, the most commonly used illicit substance worldwide, is associated with an increased occurrence of head and neck cancer. A study from the USC Head and Neck Center, ...

Adding neoadjuvant and adjuvant pembrolizumab to the standard of care significantly improved event-free survival in patients with previously untreated, locally advanced head and neck squamous cell ...

Barbara Burtness, MD highlights key news in head and neck cancer from ESMO 2025, including CAMORAL, ASPEN-03 & -04, OrigAMI-4 & -05 results.

MSK radiation oncologist Dr. Nancy Lee helped design the clinical trial showing that immunotherapy given around surgery could reduce recurrence of some head and neck cancers. A phase 3 clinical trial ...